TY - JOUR
T1 - Mucinous adenocarcinomas of nose and paranasal sinuses
AU - Gamez‐Araujo, J. J.
AU - Ayala, Alberto
AU - Guillamondegui, Oscar
PY - 1975/1/1
Y1 - 1975/1/1
N2 - This study concerns 18 patients with mucinous adenocarcinomas of nose and/or paranasal sinuses. Males in the 5th decade of life predominated in the series. Nasal obstruction, a growing mass in a sinus, or epistaxis were the most frequent complaints. Ten patients had tumors in the maxillary antrum, and the nasal cavity was the site in 5 patients. Histopathologically, the tumors were papillary or solid. The majority of the papillary tumors were moderately to well differentiated, with a few poorly differentiated types. Tumors with the solid pattern of growth were anaplastic; these patients had poorer prognoses. For most patients, treatment consisted of radical surgery alone or in combination with radiotherapy. Of 13 patients for whom survival could be adequately evaluated, 7 died from the tumors, 5 are alive and free of disease more than 4 years, and 1 is living with recurrent tumor 14 months after diagnosis.
AB - This study concerns 18 patients with mucinous adenocarcinomas of nose and/or paranasal sinuses. Males in the 5th decade of life predominated in the series. Nasal obstruction, a growing mass in a sinus, or epistaxis were the most frequent complaints. Ten patients had tumors in the maxillary antrum, and the nasal cavity was the site in 5 patients. Histopathologically, the tumors were papillary or solid. The majority of the papillary tumors were moderately to well differentiated, with a few poorly differentiated types. Tumors with the solid pattern of growth were anaplastic; these patients had poorer prognoses. For most patients, treatment consisted of radical surgery alone or in combination with radiotherapy. Of 13 patients for whom survival could be adequately evaluated, 7 died from the tumors, 5 are alive and free of disease more than 4 years, and 1 is living with recurrent tumor 14 months after diagnosis.
UR - http://www.scopus.com/inward/record.url?scp=0016747029&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0016747029&partnerID=8YFLogxK
U2 - 10.1002/1097-0142(197509)36:3<1100::AID-CNCR2820360339>3.0.CO;2-R
DO - 10.1002/1097-0142(197509)36:3<1100::AID-CNCR2820360339>3.0.CO;2-R
M3 - Article
C2 - 171052
AN - SCOPUS:0016747029
SN - 0008-543X
VL - 36
SP - 1100
EP - 1105
JO - Cancer
JF - Cancer
IS - 3
ER -